Cytogen, Inc. (KOSDAQ:217330)
South Korea
· Delayed Price · Currency is KRW 3,410.00
-105.00 (-2.99%)
At close: Dec 5, 2025
Cytogen Revenue
Cytogen had revenue of 7.63B KRW in the quarter ending September 30, 2025, with 128.53% growth. This brings the company's revenue in the last twelve months to 25.09B, up 305.67% year-over-year. In the year 2024, Cytogen had annual revenue of 10.91B with 242.63% growth.
Revenue (ttm)
25.09B
Revenue Growth
+305.67%
P/S Ratio
3.13
Revenue / Employee
n/a
Employees
42
Market Cap
78.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.91B | 7.73B | 242.63% |
| Dec 31, 2023 | 3.18B | 2.42B | 318.57% |
| Dec 31, 2022 | 760.78M | 412.93M | 118.71% |
| Dec 31, 2021 | 347.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition